The arrival of this medication in Oz is generating significant interest within the weight loss community. This innovative dual agonist – targeting both GLP-1 and GIP targets – offers a potentially effective option https://bookmarkfox.com/story7775879/retatrutide-australia-a-possible-new-approach-for-body-control